Skip to main content
Log in

1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone, a new synthetic antihypertensive agent

  • Specialia
  • Chimica. Biochimica
  • Published:
Experientia Aims and scope Submit manuscript

Zusammenfassung

1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone (I; CIBA 1002-Go), senkt an normotonischen und hypertonischen Tieren den Blutdruck. Die Drucksenkung kann auf eine periphere Vasodilatation und eine Hemmung hypothalamischer oder medullärer Vasomotorenzentren bezogen werden. Ausserdem wirkt CIBA 1002-Go adrenolytisch.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. V. P. Arya, inCNS Drugs (Council of Scientific and Industrial Research, New Delhi 1966), p. 35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Hydrochloride = CIBA 1002-Go.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arya, V.P., Grewal, R.S., David, J. et al. 1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone, a new synthetic antihypertensive agent. Experientia 23, 514–515 (1967). https://doi.org/10.1007/BF02137938

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02137938

Keywords

Navigation